Colgate-Palmolive gains after Q3 sales beat, higher earnings forecast

What happened

Colgate-Palmolive shares rose about 4.1% before the market opened after third-quarter organic sales grew 3.6%, beating the 3.17% analyst estimate. Net sales rose 4.6% to $5.37 billion, and the company raised its full-year earnings growth forecast.

Confirmed

Global impact / market context

Higher sales and an improved profit outlook suggest Colgate is selling more while keeping more profit per sale, which can support future earnings. Investors often treat such beats as a sign that pricing power and cost control are working.

Analyst inference

The results show growth was uneven: Asia Pacific and Hill's Pet Nutrition beat estimates, while North American organic sales fell 1.6%. That regional weakness, with volume down 3.7%, signals some shoppers are buying less even as prices rise.

Analyst inference

What to watch

1. Colgate narrowed its 2026 net sales growth forecast to 4.5% from 4% at the midpoints previously and raised its Base Business earnings per share growth outlook. Confirmed
2. Gross profit margin rose 80 basis points to 60.2%, which means Colgate kept more profit from each sale after subtracting the direct cost of goods. Confirmed
3. Watch whether North American volume keeps falling, because continued weakness there could offset gains in Asia Pacific and pet nutrition and pressure future sales growth. Analyst inference

Evidence

• seekingalpha.com